Description
Incruse (umeclidinium (umeclidinium bromide)) is an umeclidinium bromide listed in our Respiratory medications and inhalers directory and prescribed for chronic obstructive pulmonary disease (1.1) (2.1). Administered via the inhalation route, Incruse is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Incruse is a medication containing the active pharmaceutical ingredient umeclidinium (umeclidinium bromide), classified pharmacologically as an umeclidinium bromide (2.1). It is clinically indicated for the management of chronic obstructive pulmonary disease as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Respiratory medications and inhalers section of our catalogue, patients and prescribers frequently review Incruse alongside related therapies such as Acetylcysteine, Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), Advair (Fluticasone Propionate / Salmeterol Xinafoate), and Aermony RespiClick PD (Fluticasone Propionate).
How Incruse Works
The active ingredient, umeclidinium (umeclidinium bromide), acts on targeted physiological pathways associated with chronic obstructive pulmonary disease to help achieve therapeutic control when used consistently alongside lifestyle and clinical monitoring measures recommended by your prescriber (2.1).
What is COPD?
Chronic obstructive pulmonary disease causes persistent breathing limitation. Treatment can include inhaled medicines, smoking cessation, rehabilitation, and an exacerbation plan. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete COPD condition guide for appointment questions and related therapies (2.1).
Ordering Incruse from Canada for U.S. Delivery
U.S. patients can order Incruse (Umeclidinium) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Incruse |
| Chemical / Generic Name | Umeclidinium (Umeclidinium Bromide) |
| Pharmacological Class | UMECLIDINIUM BROMIDE |
| Therapeutic Category | Respiratory medications and inhalers |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Inhalation |
| Primary Indications | Chronic Obstructive Pulmonary Disease |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| Catalogue Index Links | Letter I Index · All Medications · All Categories |
Directions
Administration Guidance
Administer Incruse strictly via the prescribed inhalation device according to the schedule set by your healthcare provider (2.1). Prime, load, inhale, and clean the inhaler exactly as shown in the manufacturer’s patient leaflet. If using an inhaled corticosteroid preparation, rinse your mouth with water and spit out after each dose when directed to reduce local throat irritation.
Missed Dose Guidance
If you miss a scheduled dose of Incruse, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Incruse is umeclidinium (umeclidinium bromide) (2.1).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Key Clinical Precautions
Before starting or continuing Incruse, discuss your complete medical history with your healthcare provider. Key clinical cautions include (2.1):
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
Interactions
Important Interaction Categories
Concomitant use of Incruse with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Potassium supplements, potassium-sparing diuretics (such as Aldactone (Spironolactone), eplerenone, triamterene, or amiloride), and salt substitutes: Concomitant use can lead to clinically significant hyperkalemia (elevated serum potassium). Regular electrolyte monitoring is recommended.
Side effects
Like all medications, Incruse can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (2.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; eating smaller, lower-fat meals and avoiding lying down immediately after eating may help reduce nausea.
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Xerostomia (dry mouth): Sipping water or using sugar-free lozenges can help relieve oral dryness.
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Store Incruse in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (2.1).
Frequently Asked Questions About Incruse
What is Incruse and what active ingredient does it contain?
Incruse is an umeclidinium bromide containing the active pharmaceutical ingredient umeclidinium (umeclidinium bromide). It is supplied for inhalation administration and requires a valid prescription where applicable.
How does Incruse work in the body?
Incruse (umeclidinium (umeclidinium bromide)) works through targeted pharmacological pathways in its class (umeclidinium bromide) to support the clinical management of chronic obstructive pulmonary disease.
What conditions is Incruse prescribed to treat?
Incruse is primarily indicated for chronic obstructive pulmonary disease. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Incruse?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Incruse is administered via the inhalation route. Inhale or administer it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Incruse?
Commonly reported side effects of Incruse include feeling sick, loose stools, constipation, headache, dizziness, and dry mouth. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Incruse?
Important interaction categories for Incruse include potassium-containing products. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Incruse be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Incruse to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Incruse online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Incruse (Umeclidinium) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Incruse have a generic equivalent (Umeclidinium) at a Canada pharmacy?
Currently, Incruse (Umeclidinium) is dispensed in our catalogue as a brand-name formulation. Check our Umeclidinium active ingredient hub for updates as licensed generic presentations become available.
How is Incruse shipped to U.S. residents, and how much does shipping cost?
Incruse ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Incruse prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Incruse prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Incruse (Umeclidinium Bromide) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Incruse Ellipta product monograph. Health Canada / authorization holder. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: COPD. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
